No Association of TGF-β1 Antigen with the Development of Restenosis in Patients Undergoing Peripheral Angioplasty

Thromb Haemost 2000; 84(03): 518-519
DOI: 10.1055/s-0037-1614056

Letters to the Editor

Schattauer GmbH

R. E. Roller

¹From the Department of Internal Medicine, Karl Franzens University School of Medicine Graz, Graz, Austria

,

A. Obernosterer

¹From the Department of Internal Medicine, Karl Franzens University School of Medicine Graz, Graz, Austria

,

A. Dorr

,

W. J. Schnedl

¹From the Department of Internal Medicine, Karl Franzens University School of Medicine Graz, Graz, Austria

References
1 Saltis J, Agrotis A, Bobik A. Regulation and interactions of transforming growth factor-beta with cardiovascular cells: implications for development and disease. Clin Experim Pharmacol Physiol 1996; 23: 193-200.
2 Falciani M, Gori AM, Giusti B, Fedi S, Capanni M, Simonetti I, Margheri M, Prisco D, Abbate R, Gensini GF. Percutaneous transluminal coronary angioplasty procedure is associated to a decrease in transforming growth factor beta 1 levels. Thromb Haemost 1999; 82: 1204-5.
3 Ward MR, Agrotis A, Kanellakis P, Dilley R, Jennings J, Bobik A. Inhibition of protein tyrosine kinase attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury. Arterioscl Thromb & Vasc Biol 1997; 17: 2461-70.